3/13
07:59 am
regn
Rating for REGN
Low
Report
Rating for REGN
3/13
07:59 am
regn
Rating for REGN
Low
Report
Rating for REGN
3/12
08:02 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,125.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $1,125.00 price target on the stock.
3/12
05:27 am
regn
Rating for REGN
Low
Report
Rating for REGN
3/12
05:27 am
regn
Rating for REGN
Low
Report
Rating for REGN
3/11
04:43 pm
regn
Rating for REGN
Low
Report
Rating for REGN
3/11
04:43 pm
regn
Rating for REGN
Low
Report
Rating for REGN
2/27
09:55 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/27
09:55 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/6
09:36 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
10:32 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
10:32 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
09:13 am
regn
Rating for REGN
Low
Report
Rating for REGN
2/5
09:13 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/29
01:10 pm
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,076.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,076.00 price target on the stock.
1/29
01:10 pm
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,076.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $1,076.00 price target on the stock.
1/29
12:43 pm
regn
Rating for REGN
Low
Report
Rating for REGN
1/29
12:43 pm
regn
Rating for REGN
Low
Report
Rating for REGN
1/23
08:20 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/23
08:20 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/12
07:00 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $1,076.00 price target on the stock, up previously from $884.00.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $1,076.00 price target on the stock, up previously from $884.00.
1/12
07:00 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $1,076.00 price target on the stock, up previously from $884.00.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $1,076.00 price target on the stock, up previously from $884.00.
1/12
06:43 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/12
06:43 am
regn
Rating for REGN
Low
Report
Rating for REGN
1/9
09:18 am
regn
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $850.00 price target on the stock.
Low
Report
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $850.00 price target on the stock.